Inhibitor of β‐catenin and T‐cell factor (ICAT) promotes colorectal cancer (CRC) cell migration and invasion by interacting with the junction plakoglobin (JUP) and via the NF‐κB signaling pathway in CRC. This evidence concerns the gene NFKB1 and colorectal carcinoma.